EpiCenter for Emerging Infectious Disease Intelligence
Project Number3U01AI151814-05S1
Contact PI/Project LeaderJOHNSON, CHRISTINE KREUDER Other PIs
Awardee OrganizationUNIVERSITY OF CALIFORNIA AT DAVIS
Description
Abstract Text
Project Summary/Abstract:
The Epicenter for Emerging Infectious Disease Intelligence brings together a consortium of leading research
institutions to advance an understanding of viral emergence from wildlife into humans living in forest and rapidly
urbanizing ecosystems. Our work will enhance preparedness for disease emergence events in the Congo Basin
and Amazon Basin forest regions and facilitate response efforts at the source of emergence. Our multidisciplinary
team has internationally recognized expertise in infectious disease epidemiology, virology, human health, animal
health, medical entomology, microbiology, and disease modeling. Our proposed activities integrate human,
animal, and vector surveillance to enable insight into cross-species disease transmission and facilitate
responsiveness to evolving needs that impact country, regional, and global emerging infectious disease risk. In
our initial work, we propose to investigate the epidemiology of arboviruses and filoviruses, which include
emerging viruses currently threatening global health security. We will evaluate disease transmission dynamics
at the primary stage of emergence in humans, in forest communities where people are highly susceptible to virus
spillover from wildlife and mosquitos. We will also investigate these viruses in the second stage of emergence,
in urban centers peripherally connected to forests, where viruses have adapted to human-to-human transmission
(by direct or vector-borne transmission). Targeted filoviruses and arboviruses at proposed sites in Uganda and
Peru represent a range of emergence histories, from recent emergence events, to seasonal and annual re-
emergence events, to introduction events where viruses have adapted to entirely new ecosystems, vectors, and
vertebrate hosts. Research at these sites will advance our understanding of cross-species transmission for
viruses across this spectrum of emergence. Our work will optimize best practices in acute febrile illness
surveillance in high-risk communities coupled with wildlife and entomologic risk characterization studies to
facilitate deployment of next generation techniques in early detection of virus emergence and monitoring of
sustained transmission in at-risk communities. Our consortium has a demonstrated commitment to strengthening
international capabilities for emerging infectious disease research in resource-limited countries. We are well-
poised to contribute to important advances in capacity in the Amazon and Congo Basin forest region with
partners in Uganda and Peru for completion of our proposed project and long-term sustainability for the greater
region and across the Emerging Infectious Disease Research Center network.
Public Health Relevance Statement
Project Narrative:
The Epicenter for Emerging Infectious Disease Intelligence will establish research hubs in the Amazon and
Congo Basin forest for emerging infectious disease research, building on our demonstrated commitment to
capacity strengthening in these regions. Our proposed research will enhance surveillance for arboviruses and
filoviruses in acute febrile illness cases, vectors, and vertebrate hosts that are perpetuating transmission in
forest and urban systems. This work will advance an understanding of cross-species transmission dynamics
for emerging viral threats, as well as optimize innovative and deployable surveillance and testing strategies to
strengthen infectious disease surveillance and enable rapid response to outbreaks as part of the Emerging
Infectious Disease Research Center network.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
047120084
UEI
TX2DAGQPENZ5
Project Start Date
13-July-2020
Project End Date
31-May-2026
Budget Start Date
01-June-2024
Budget End Date
31-May-2026
Project Funding Information for 2024
Total Funding
$391,379
Direct Costs
$372,432
Indirect Costs
$18,947
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$391,379
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U01AI151814-05S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01AI151814-05S1
Patents
No Patents information available for 3U01AI151814-05S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01AI151814-05S1
Clinical Studies
No Clinical Studies information available for 3U01AI151814-05S1
News and More
Related News Releases
No news release information available for 3U01AI151814-05S1
History
No Historical information available for 3U01AI151814-05S1
Similar Projects
No Similar Projects information available for 3U01AI151814-05S1